Your browser doesn't support javascript.
loading
Development of a Ligand Screening Tool Using Full-Length Human Peroxisome Proliferator-Activated Receptor-Expressing Cell Lines to Ameliorate Metabolic Syndrome.
Tachibana, Keisuke; Ishimoto, Kenji; Takahashi, Rika; Kadono, Hirokazu; Awaji, Takuya; Yuzuriha, Tomohiro; Tanaka, Toshiya; Hamakubo, Takao; Sakai, Juro; Kodama, Tatsuhiko; Aoki, Shunji; Doi, Takefumi.
Afiliación
  • Tachibana K; Graduate School of Pharmaceutical Sciences, Osaka University.
  • Ishimoto K; Graduate School of Pharmaceutical Sciences, Osaka University.
  • Takahashi R; Graduate School of Pharmaceutical Sciences, Osaka University.
  • Kadono H; Graduate School of Pharmaceutical Sciences, Osaka University.
  • Awaji T; Graduate School of Pharmaceutical Sciences, Osaka University.
  • Yuzuriha T; Faculty of Pharmaceutical Sciences, Setsunan University.
  • Tanaka T; Laboratory for System Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo.
  • Hamakubo T; Department of Protein-Protein Interaction Research, Institute for Advanced Medical Sciences, Nippon Medical School.
  • Sakai J; Division of Metabolic Medicine, Research Center for Advanced Science and Technology, The University of Tokyo.
  • Kodama T; Laboratory for System Biology and Medicine, Research Center for Advanced Science and Technology, The University of Tokyo.
  • Aoki S; School of Pharmacy, Hyogo University of Health Sciences.
  • Doi T; Graduate School of Pharmaceutical Sciences, Osaka University.
Chem Pharm Bull (Tokyo) ; 67(3): 199-202, 2019.
Article en En | MEDLINE | ID: mdl-30827999
ABSTRACT
Peroxisome proliferator-activated receptors (PPARs) belong to the nuclear hormone receptor superfamily and include three subtypes (PPARα, PPARδ, and PPARγ). They regulate gene expression in a ligand-dependent manner. PPARα plays an important role in lipid metabolism. PPARγ is involved in glucose metabolism and is a potential therapeutic target in Type 2 diabetes. PPARδ ligands are candidates for the treatment of metabolic disorders. Thus, the detection of PPAR ligands may facilitate the treatment of various diseases. In this study, to identify PPAR ligands, we engineered reporter cell lines that can be used to quantify PPARγ and PPARδ activity. We evaluated several known ligands using these reporter cell lines and confirmed that they are useful for PPAR ligand detection. Furthermore, we evaluated extracts of approximately 200 natural resources and found various extracts that enhance reporter gene activity. Finally, we identified a main alkaloid of the Evodia fruit, evodiamine, as a PPARγ activator using this screening tool. These results suggest that the established reporter cell lines may serve as a useful cell-based screening tool for finding PPAR ligands to ameliorate metabolic syndromes.
Asunto(s)
Palabras clave

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome Metabólico / Receptores Activados del Proliferador del Peroxisoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2019 Tipo del documento: Article

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Síndrome Metabólico / Receptores Activados del Proliferador del Peroxisoma Tipo de estudio: Diagnostic_studies / Prognostic_studies / Screening_studies Idioma: En Revista: Chem Pharm Bull (Tokyo) Año: 2019 Tipo del documento: Article